Delivery Order SPE2DB22D3102-SPE2DB25FK9BX

Award Date 11/20/24
Potential Completion Date 12/12/24
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9BX
    Delivery Order

This firm-fixed-price delivery order, valued at $6,508.32, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XEOMIN 100 unit vials, with a completion date of December 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order is part of Amerisourcebergen's broad spectrum of pharmaceutical and medical supply contracts with federal agencies, particularly the DLA Troop Support Medical, which covers various therapeutic areas and medical commodities to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/19/25, 9:13 AM